Clinical Trial Update: Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes [Phase 4]

View source ↗

Summary

Pilot Phase 4 trial evaluating fenfluramine for various developmental and epileptic encephalopathies, including SYNGAP1 and STXBP1-related conditions, with outc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Continuous Spike and Waves During Slow Sleep
• Epilepsy
• Inv Dup Encephalopathy
• Multifocal or Bilateral Malformations of Cortical Development
• Stxbp1 Encephalopathy with Epilepsy
• Syngap1 Encephalopathy

Drugs mentioned

• Fenfluramine (fenfluramine)

Snippet

Sponsor: Hospital Ruber Internacional | Conditions: Refractory Epilepsy, SYNGAP1 Encephalopathy | Phase 4 | Status: UNKNOWN